Companies' margins seen firm in Oct-Dec despite slow growth - CRISIL

MUMBAI Wed Jan 2, 2013 4:18pm IST

A worker paints sifts used for cement filtration at a manufacturing factory in the industrial area of Kolkata June 12, 2012. REUTERS/Rupak De Chowdhuri/Files

A worker paints sifts used for cement filtration at a manufacturing factory in the industrial area of Kolkata June 12, 2012.

Credit: Reuters/Rupak De Chowdhuri/Files

Related Topics

MUMBAI (Reuters) - Indian companies are likely to see their EBITDA (earnings before interest, taxes, depreciation and amortisation) margins staying firm in October-December, despite continuing pressures on demand growth, CRISIL Research said in a note on Wednesday.

"EBITDA margins will be supported by increasing realisations and softening prices of commodities such as coal, rubber and cotton," Mukesh Agarwal, president at CRISIL Research, said.

"In addition, stringent cost control by corporates across sectors would further cushion margins," he said.

Excluding banks and oil and gas companies, EBITDA margins are estimated to improve marginally by 10-30 basis points year-on-year in the three months to December, while revenue growth is expected to be muted at 11-13 percent, CRISIL said.

However, overcapacity is expected to dent margins for hotel and shipping companies, while high input costs will drag profitability in paper and petrochemicals.

Sectors such as sugar, tyre, cement and airlines would see an expansion of over 250 basis points year-on-year in EBITDA margins due to higher realisations, Prasad Koparkar, Senior Director, CRISIL Research, said.

Lower input costs would result in higher margins for power generation, textile and tyre companies, he said.

Volume growth is estimated to be muted in the October-December quarter due to weak consumer sentiment and continued macro-economic pressures, CRISIL Research said.

India's economy grew 5.3 percent from a year earlier in July-September and is on track for its worst year in a decade.

(Reporting by Shamik Paul; Editing by Sunil Nair)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Drug Pricing

REUTERS SHOWCASE

 G20 Meet

G20 Meet

As G20 chases growth goal, members differ on how to get there   Full Article 

Modi Speaks

Modi Speaks

PM Modi says al Qaeda will fail in India - CNN.  Full Article 

Alibaba Listing

Alibaba Listing

Alibaba surges on massive demand in trading debut  Full Article 

Importing Rice

Importing Rice

Top rice exporter India importing over 100,000 T on temporary supply squeeze.  Full Article 

GSK Fined

GSK Fined

China hands drugmaker GSK record $489 mln fine, sentences executives.  Full Article 

HMT in Demand

HMT in Demand

Fans rush to HMT as watchmaker marks time.  Full Article 

Apple Not Cool?

Apple Not Cool?

Some consumers say Apple is losing its "cool" factor  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage